Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Standard Biotools (LAB) Tax Provisions (2016 - 2026)

Standard Biotools has reported Tax Provisions over the past 16 years, most recently at $2.8 million for Q4 2025.

  • Quarterly Tax Provisions rose 926.47% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $816000.0 through Dec 2025, up 51.39% year-over-year, with the annual reading at $892000.0 for FY2025, 64.58% up from the prior year.
  • Tax Provisions was $2.8 million for Q4 2025 at Standard Biotools, up from -$1.2 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $3.4 million in Q4 2022 and troughed at -$1.7 million in Q1 2021.
  • The 5-year median for Tax Provisions is -$30000.0 (2023), against an average of -$55684.2.
  • Year-over-year, Tax Provisions soared 1006.67% in 2024 and then plummeted 1661.54% in 2025.
  • A 5-year view of Tax Provisions shows it stood at -$1.4 million in 2021, then surged by 342.29% to $3.4 million in 2022, then plummeted by 100.88% to -$30000.0 in 2023, then soared by 1006.67% to $272000.0 in 2024, then soared by 926.47% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Tax Provisions are $2.8 million (Q4 2025), -$1.2 million (Q3 2025), and -$609000.0 (Q2 2025).